BRUNELLESCHI, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 2.409
EU - Europa 2.293
AS - Asia 570
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 1
Totale 5.280
Nazione #
US - Stati Uniti d'America 2.393
IE - Irlanda 671
SE - Svezia 495
DE - Germania 475
UA - Ucraina 318
FI - Finlandia 198
HK - Hong Kong 189
CN - Cina 168
SG - Singapore 107
IN - India 79
IT - Italia 77
GB - Regno Unito 30
IR - Iran 22
CA - Canada 16
FR - Francia 14
EU - Europa 7
MT - Malta 3
RU - Federazione Russa 3
BE - Belgio 2
CZ - Repubblica Ceca 2
RO - Romania 2
TR - Turchia 2
CL - Cile 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 5.280
Città #
Dublin 671
Jacksonville 546
Dearborn 267
Chandler 265
Hong Kong 189
Wilmington 168
Lawrence 93
Princeton 93
Beijing 76
San Mateo 74
Andover 71
Singapore 71
Ann Arbor 63
Ashburn 62
Woodbridge 61
Houston 45
Philadelphia 44
Boardman 35
Munich 35
Bremen 34
Piemonte 33
Hefei 20
Helsinki 16
Norwalk 15
Monmouth Junction 13
Leawood 12
Toronto 12
Kunming 10
Santa Clara 10
Düsseldorf 9
Nanchang 9
Nanjing 8
Ardabil 6
Zanjan 6
Jinan 5
Rome 5
Auburn Hills 4
Augusta 4
Berlin 4
Los Angeles 4
Ottawa 4
Turin 4
Cassano Magnago 3
Chengdu 3
Fairfield 3
Fuzhou 3
Hebei 3
Novara 3
Salerno 3
Seattle 3
Brno 2
Brussels 2
Changsha 2
Chatsworth 2
Gunzenhausen 2
Haikou 2
Henderson 2
Portland 2
Saluggia 2
Shaoxing 2
Torino 2
Zhengzhou 2
Athens 1
Cagliari 1
Cambridge 1
Castelnuovo Bormida 1
Chaoyang 1
Chongqing 1
Dallas 1
Des Moines 1
Gattinara 1
Ghemme 1
Grafenhausen 1
Guangzhou 1
Hangzhou 1
Harbin 1
Horia 1
Kemerovo 1
Kocaeli 1
Langfang 1
London 1
Madrid 1
Milan 1
Mumbai 1
Mülheim 1
Nanning 1
Nottingham 1
Nuremberg 1
Sacramento 1
San Diego 1
Shanghai 1
Shenyang 1
Simi Valley 1
Strasbourg 1
Taizhou 1
Tallinn 1
Trumbull 1
Varallo 1
Wenzhou 1
Xian 1
Totale 3.262
Nome #
Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients 92
Protein Kinase C (PKC) and neuropeptidergic stimulation of alveolar macrophages (AMs) 81
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 80
Interference of WEB 2086 and BN 52021 with paf-induced effects on guinea-pig trachea 77
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 75
Anti-inflammatory properties of clovamide and Theobroma cacao phenolic extracts in human monocytes: evaluation of respiratory burst, cytokine release, NFkB activation and PPARγ modulation 74
Tachykinins stimulate lyso-PAF-acetyl-CoA acetyltransferase activity in neutrophils 73
Tachykinin activation of human monocytes from normal and rheumatoid patients: effects of cyclosporine 73
Immunological modulation of cholinergic histamine release in isolated rat mast cells 71
Mast cell and neutrophil interactions: a role for superoxide anion and histamine 71
Synthesis and study of the anti-inflammatory properties of some pyrazolo[1,5-a]pyrimidine derivatives 71
Correlation between cholinergic histamine release and quinuclidinyl-benzilate ([3H]-QNB) binding in mast cell membranes 70
Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands 70
FMLP-activated neutrophils evoke histamine release from mast cells 69
Coronary effects of cyclovirobuxine D in anesthetized pigs and in isolated porcine coronary arteries 68
The pharmacological properties of 1,4-dihydro-1-ethyl-7-phenylpyrrol(1,2-a)-pyrimidine-4-one, a new antipyretic and analgesic drug 67
Drug modulation of superoxide anion production from human neutrophils 66
The release of histamine by parasympathetic stimulation of guinea-pig auricle and rat ileum 66
Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles 66
Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kB oathway 66
A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages 66
Ticagrelor: a novel drug for an old problem 65
Muscarinic cholinergic receptor binding in rat mast cells 64
Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-kappaB pathway 64
Vortioxetine exerts antiinflammatory and immunomodulatory effects on human monocytes/macrophages. 64
Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study) 64
The antianaphylactic action of histamine H2 agonists in the isolated guinea-pig heart 64
Peroxisome proliferator-activated receptor-gamma expression in monocytes/macrophages from rheumatoid arthritis patients: relation to disease activity and therapy efficacy--a pilot study 64
Chemioterapici antineoplastici 63
Recurrent major depressive disorder: imbalance of neurokinin (NK)-1 and NK-2 receptor expression in monocytes 63
Enhanced peroxisome proliferator-activated receptor-gamma expression in monocyte/macrophages from coronary artery disease patients and possible gender differences 63
Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins 62
Cyclosporin A reduces tachykinin activation of human monocytes from normal and rheumatoid arthritis patients 62
BARDELLI C, AMORUSO A, GUNELLA G, FRESU LG., & S. BRUNELLESCHI. Effects of nicotine on human monocyte/macrophages in smokers and non-smokers 62
The riddle of cholinergic histamine release from mast cells 61
Platelet-Activating Factor-acether-induced relaxation og guinea-pig airway muscle: role of prostalandin E2 and the epithelium 61
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 61
Histamine release by free radicals: paracetamol-induced histamine release from rat peritoneal mast cells after in vitro activation by monooxygenase 61
Ischemia-reperfusion on human skeletal muscle during aortoiliac surgery: effects of acetylcarnitine 60
Sensory neuropeptides activate guinea-pig alveolar macrophages 60
Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: A pilot study. 59
Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappaB and implication for rheumatoid arthritis therapy 59
A possible involvement of monocyte-derived microparticles in alveolar macrophages inflammatory response. 58
Adenosine modulation of primed human neutrophils 58
Anti-inflammatory drugs and rheumatoid arthritis: A role for TNF-alpha and NF-kappa B 58
N-Formylmethionyl-leucyl-phenylalanine: different releasing effects on human neutrophils and rat mast cells 58
Coronary Artery Disease: a possible role for PPAR-γ receptors 58
Evidence for tachykinin NK-2B-like receptors in guinea-pig alveolar macrophages 57
Neuropeptide-leukocyte interactions: examples of pharmacological modulation 57
Tachykinin receptor modulators: novel therapeutics for rheumatoid arthritis 57
Hemodynamic effects of the intravenous administration of cyclovirobuxine D [correction of cyclorirobuxine D] in anesthetized pigs. 57
Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen. 57
Mediator release from isolated rat ileum in response to field stimulation 57
Evidence that histamine sensitivity and responsiveness of guinea-pig isolated trachea are modulated by epithelial prostaglandin E2 production 56
Ron tyrosine kinase receptor is implicated in telomerase regulation 56
Sostanza P e Depressione: espressione del recettore NK1, attivazione di NF-κB e rilascio di citochine in monociti di pazienti psichiatrici 56
Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome 55
Tobacco smoke affects expression of peroxisome proliferator-activated receptor-gamma in monocyte/macrophages of patients with coronary heart disease 55
Rhein. an anthraquinone that modulates superoxide anion production from human neutrophils 55
Macrophage Stimulating Protein (MSP) activates human macrophages 54
Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle 54
Priming effects of mammalian tachykinins on human neutrophils 53
Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death 53
Effects of peroxisome proliferator-activated receptor-gamma agonists on the generation of microparticles by monocytes/macrophages 53
Macrophage Stimulating Protein (MSP) evokes superoxide anion production by human macrophages of different origin 52
The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages 51
Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response 51
Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells. 51
Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors 51
Mast cell heterogeneity in response to cholinergic stimulation 50
Neuropeptidergic activation of sensitized guinea-pig alveolar macrophages 50
Quantification of PPAR-gamma protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine 49
Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study 49
Autacoid and beta-adrenergic agonist modulation of N-formylmethionyl-leucyl-phenylalanine evoked lysosomal enzyme release from human neutrophils 48
Minor polar compounds in olive oil and NF-kB translocation 48
Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kB translocation in human monocyte/macrophages 48
Tachykinin receptors on human monocytes: their involvement in rheumatoid arthritis 46
Novità farmacologiche nel trattamento delle demenze 46
Clinical and angiographic assessment of a low-dose protocol of oral Prednisone after coronary angioplasty. The IMPRESS Low-Dose Study 46
Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells 45
Modulation by protein kinase C of the enhanced responsiveness to tachykinins in ovalbumin-sensitized guinea-pig alveolar macrophages 44
Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study 43
Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers 43
Tossicita’ dei farmaci sul sistema endocrino e riproduttivo 41
Tachykinin receptors are present on human monocytes and play a role in rheumatoid arthritis 41
Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A 41
Neutropenia in patients treated with thienopyridines and high dose oral prednisone after percutaneous coronary interventions 39
On the role of autophagy in human diseases: a gender perspective 38
Modulation of neutrophil functions by a beta-interferon of human-origin 38
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography 34
Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study 33
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential 32
Gender Differences in drug responses 30
Totale 5.328
Categoria #
all - tutte 27.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020976 0 0 0 0 170 160 207 51 110 173 103 2
2020/2021648 96 3 95 3 81 19 97 1 98 5 120 30
2021/2022772 56 27 158 90 28 1 66 17 49 11 115 154
2022/20231.628 98 67 97 61 170 184 23 94 726 7 60 41
2023/2024455 43 32 32 7 83 0 68 14 0 2 127 47
2024/2025134 14 24 49 27 20 0 0 0 0 0 0 0
Totale 5.328